These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19004733)

  • 1. [Design of new protocols. Role of molecular biology units?].
    Milano G
    Bull Cancer; 2008 Oct; 95(10):1003-5. PubMed ID: 19004733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic consequences of molecular biology advances in oncology].
    Bauvet F; Awada A; Gil T; Hendlisz A
    Bull Cancer; 2009 Jan; 96(1):59-71. PubMed ID: 19211361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methodological aspects on new protocols in oncology].
    Luporsi E
    Bull Cancer; 2008 Oct; 95(10):979-83. PubMed ID: 19004729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular biological strategies in cancer. How effective are the new therapies?].
    Kaulen H
    Dtsch Med Wochenschr; 2005 Oct; Suppl 1():66-7. PubMed ID: 16379245
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer and leukemia group B breast committee: decades of progress and plans for the future.
    Hudis CA; Winer EP
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3576s-80s. PubMed ID: 16740788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biomarker for chemotherapy in patients with colorectal cancer].
    Matsusaka S
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):11-4. PubMed ID: 19151559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The convergent development of molecular-targeted drugs for cancer treatment and prevention.
    Lippman SM; Heymach JV
    Clin Cancer Res; 2007 Jul; 13(14):4035-41. PubMed ID: 17634526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the predictive role of K-ras for epidermal growth factor receptor-targeted therapies in colorectal cancer.
    Ramos FJ; Macarulla T; Capdevila J; Elez E; Tabernero J
    Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S52-7. PubMed ID: 19064407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of molecular diagnostics: solid tumor genetics can determine clinical treatment protocols.
    Cordon-Cardo C
    Mod Pathol; 2001 Mar; 14(3):254-7. PubMed ID: 11266534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating targeted agents into therapeutic regimens for patients with resectable colorectal cancer.
    Marshall JL
    Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S63-6. PubMed ID: 19064409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities.
    Modjtahedi H; Essapen S
    Anticancer Drugs; 2009 Nov; 20(10):851-5. PubMed ID: 19826350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine tumors: novel approaches in the age of targeted therapy.
    Phan AT; Yao JC
    Oncology (Williston Park); 2008 Dec; 22(14):1617-23; discussion 1623-4, 1629. PubMed ID: 19198220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3K and mTOR inhibitors: a new generation of targeted anticancer agents.
    Brachmann S; Fritsch C; Maira SM; García-Echeverría C
    Curr Opin Cell Biol; 2009 Apr; 21(2):194-8. PubMed ID: 19201591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis of cancer and the development of targeted therapy.
    Riley LB; Desai DC
    Surg Clin North Am; 2009 Feb; 89(1):1-15, vii. PubMed ID: 19186227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy.
    Desar IM; van Herpen CM; van Laarhoven HW; Barentsz JO; Oyen WJ; van der Graaf WT
    Cancer Treat Rev; 2009 Jun; 35(4):309-21. PubMed ID: 19136215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted cancer therapeutics.
    Hait WN; Hambley TW
    Cancer Res; 2009 Feb; 69(4):1263-7; discussion 1267. PubMed ID: 19208830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is tailored therapy feasible in oncology?
    Gasparini G; Longo R; Torino F; Gattuso D; Morabito A; Toffoli G
    Crit Rev Oncol Hematol; 2006 Jan; 57(1):79-101. PubMed ID: 16337806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review: new biological insights in early clinical studies.
    Maur M; Sessa C
    Hematol Oncol; 2007 Jun; 25(2):53-7. PubMed ID: 17351979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches in systemic treatment of advanced colorectal cancer: the molecular targets era.
    Capdevila J; Mendez G; Macarulla T; Ramos FJ; Casado E; Tabernero J
    Expert Rev Anticancer Ther; 2007 Jul; 7(7):1027-41. PubMed ID: 17627462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.